Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	509	297	213	707	2,006	1,242
Market Cap Growth	225.29%	39.61%	-69.88%	-64.73%	61.56%	78.51%
Enterprise Value	434	220	109	530	1,895	1,037
PE Ratio	-	-13.88	-2.23	-12.80	-16.81	-15.32
PS Ratio	6.02	3.51	3.27	20.27	96.67	-
PB Ratio	5.13	2.95	1.95	3.93	18.95	6.24
P/FCF Ratio	-40.48	-10.92	-2.81	-17.17	-21.94	-16.45
P/OCF Ratio	-40.48	-10.92	-2.81	-6.90	-21.99	-16.89
EV/Sales Ratio	5.14	2.60	1.67	15.17	91.33	-
EV/EBITDA Ratio	-26.15	-8.83	-1.16	-10.06	-15.85	-12.51
EV/EBIT Ratio	-25.41	-8.58	-1.15	-9.91	-15.80	-12.49
EV/FCF Ratio	-36.24	-8.09	-1.44	-12.85	-20.73	-13.74
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.04	0.01
Debt / EBITDA Ratio	-0.05	-0.06	-0.02	-0.07	-0.03	-0.03
Debt / FCF Ratio	-0.07	-0.05	-0.02	-0.09	-0.04	-0.03
Quick Ratio	5.47	5.02	4.18	6.79	5.87	15.25
Current Ratio	6.15	5.52	4.61	7.26	6.26	15.60
Asset Turnover	0.66	0.64	0.41	0.14	0.13	0
Interest Coverage	-	-	-125.25	-28.85	-	-
Return on Equity (ROE)	-21.40%	-20.70%	-75.50%	-25.20%	-87.80%	-62.50%
Return on Assets (ROA)	-16.90%	-16.30%	-59.60%	-22.40%	-75.00%	-55.30%
Return on Capital (ROIC)	-24.99%	-25.07%	-85.42%	-62.82%	-109.22%	-41.27%
Earnings Yield	-4.26%	-7.20%	-44.85%	-7.81%	-5.95%	-6.53%
FCF Yield	-3.46%	-9.15%	-35.63%	-5.83%	-4.56%	-6.08%
Buyback Yield / Dilution	-0.25%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%
Total Shareholder Return	-0.25%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).